Acute effects on isolated adult rat cardiac myocyte contraction and calcium handling
Cell-based study · Isolated adult female Sprague-Dawley rat ventricular myocytes [1]
At 5 and 10 µM, 4OHT reduced sarcomere shortening and calcium-transient peak height, and prolonged time to 50% mechanical relaxation. Resting sarcomere length, resting calcium signal and time to 50% calcium decay showed no significant changes in Figure 4. A separate cell-counting readout showed fewer stimulated cells contracting at 10 µM by 45 minutes. These are acute isolated-cell observations.
| Endpoint | Reported result | Reference |
|---|---|---|
| Sarcomere shortening and relaxation | Qualitative comparison 5 µM: reduced peak height (P < 0.05), longer time to 50% relaxation (P < 0.05); 10 µM: reduced peak height (P < 0.001), longer time to 50% relaxation (P < 0.01). Resting length: no significance indicated. | [1] |
| Calcium-transient amplitude and kinetics | Qualitative comparison Peak calcium signal reduced at 5 and 10 µM (P < 0.01 for each). No significant change indicated for resting calcium signal or time to 50% calcium decay. | [1] |
| Percentage of contracting rod-shaped myocytes relative to baseline | Qualitative comparison At 45 min, 10 µM reduced contracting-cell percentage versus 0 µM (P < 0.001). No exact percentage extracted from the curve. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 0.5, 1, 3, 5 and 10 µM in concentration-response assays; Figure 3B shows 0, 5 and 10 µM.
- Exposure duration
- Sarcomere data collected 15–45 min after stimulation began; calcium: 3 min stimulation followed by 20 min collection; contracting-cell counts through 45 min.
- Method
- Acute application in modified Tyrode’s solution; different concentrations tested in random order; fresh working stocks used because precipitation occurred over time.
- Vehicle
- Methanol stock; total vehicle held constant across concentrations, with 0 µM vehicle control. Final vehicle fraction not stated in read text.
- Reported limits
- Exact isomer ratio of the experimental lot and A12532 lot equivalence were not established. SI Table S2 not retrieved; no tabulated means borrowed or estimated.
Methods and source locations
Compound reported in the paper: 4-Hydroxytamoxifen; Compound label in the paper: 4OHT; Sigma-Aldrich H6278
Results apply to the reported H6278 material and isolated rat-cell conditions; mixture ratios and supplier lots may differ. No in-vivo cardiac toxicity or Adooq lot validation is claimed.
Methods §§Treatments, Sarcomere Length Measurements, Myocyte Contractility, Calcium Handling, Statistical Analysis; Results §4-Hydroxytamoxifen; Figures 3B and 4B–H
Sarcomere shortening and relaxation: Ionoptix; 0.2 Hz, 36 ± 1°C; mean ± SEM, N = 45–50 cells/treatment from four preparations; Dunnett comparisons against 0 µM. — Figure 4B–D and caption; Methods §§Sarcomere Length Measurements, Statistical Analysis
Calcium-transient amplitude and kinetics: Fura-2AM, 360/380 nm ratio; 0.5 Hz, 36 ± 1°C; mean ± SEM, N = 38–42 cells/treatment from three preparations; Dunnett comparisons against 0 µM. — Figure 4F–H and caption; Methods §§Calcium Handling, Statistical Analysis
Percentage of contracting rod-shaped myocytes relative to baseline: Counting 30–50 cells per field at baseline, 5, 15, 30 and 45 min; 0.2 Hz; mean ± SEM; N = 3–4 counting experiments/treatment; repeated-measures ANOVA/Bonferroni. — Figure 3B and caption; Methods §§Myocyte Contractility, Statistical Analysis